Skip to main content
Clinical Trials/PACTR202003714748946
PACTR202003714748946
Completed
未知

The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropathy: A unicenter double-blind, randomized clinical trial

Not provided0 sites22 target enrollmentMarch 6, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Nutritional, Metabolic, Endocrine
Sponsor
Not provided
Enrollment
22
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • All were patients with type 2 diabetes who had daily pain or painful paresthesias in a neuropathic or radiculopathic distribution, intensity between 4 and 7 on a visual analogic scale, interfering with daily activities, work or sleep for at least 3 months duration.

Exclusion Criteria

  • History of allergies to any capsaicin product
  • Diabetic patients with other diagnosed etiology responsible for peripheral neuropathy such as hepatitis, AIDS, Nutritional deficiencies (folate, vitamin B12\)
  • Presence of open skin lesions at the site of application of the study medication
  • Signs of infection on limbs or amputations
  • Pregnant or lactating females
  • Subjects with other topical medication at site of application of study cream.
  • All eligible patients who did not give their signed informed consent to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials